Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Courtney

Showing results (481-490 of 539) with videos related to

Pageof 54
Sort By:
ACS Biomaterials Science & Engineering|June 21, 2022
Nanoligomers Targeting Human miRNA for the Treatment of Severe COVID-19 Are Safe and Nontoxic in MiceColleen R McCollum, Colleen M Courtney, Nolan J O'Connor, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2020
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Dose Selection for ME1100, an Arbekacin Inhalation SolutionSujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.
Cureus|November 14, 2025
Piloting Temperature-Driven Variability in Emergency Diagnostic Accuracy Using a Leading Large Language ModelPhilip C Jarrett, Jared Hill, Marshall Howell, et al.
Journal of the American Chemical Society|January 13, 2005
Glyco- and peptidomimetics from three-component Joullié-Ugi coupling show selective antiviral activityTimothy M Chapman, Ieuan G Davies, Baohua Gu, et al.
Chemmedchem|July 29, 2010
Discovery of a novel Hsp90 inhibitor by fragment linkingJohn J Barker, Oliver Barker, Stephen M Courtney, et al.
Canadian Journal of Diabetes|April 13, 2024
Association of Fructosamine Levels With Glycemic Management in Children With Type 1 Diabetes as Determined by Continuous Glucose Monitoring: Results From the CGM TIME TrialKate C Verbeeten, Ken Tang, Jennilea M Courtney, et al.
British Journal of Cancer|November 15, 2000
Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findingsE Tartour, M Mehtali, X Sastre-Garau, et al.
Clinical Pharmacology in Drug Development|May 16, 2023
A Phase 1 First-in-Human Single-Ascending-Dose Trial With ESB1609, a Selective Agonist to the Sphingosine-1-Phosphate Receptor 5Nicholas P France, Christopher Rubino, M Courtney Safir, et al.
Mabs|January 3, 2024
Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector functionJennifer L Schwedler, Maxwell A Stefan, Christine E Thatcher, et al.
The Journal of Arthroplasty|October 23, 2018
Hip and Knee Section, Pathogen Factors: Proceedings of International Consensus on Orthopedic InfectionsJulia Herkenhoff Carijo, Paul M Courtney, Karan Goswami, et al.
Pageof 54

Showing results (481-490 of 539) with videos related to

Sort By:
Pageof 54
ACS Biomaterials Science & Engineering|June 21, 2022
Nanoligomers Targeting Human miRNA for the Treatment of Severe COVID-19 Are Safe and Nontoxic in MiceColleen R McCollum, Colleen M Courtney, Nolan J O'Connor, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2020
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Dose Selection for ME1100, an Arbekacin Inhalation SolutionSujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.
Cureus|November 14, 2025
Piloting Temperature-Driven Variability in Emergency Diagnostic Accuracy Using a Leading Large Language ModelPhilip C Jarrett, Jared Hill, Marshall Howell, et al.
Journal of the American Chemical Society|January 13, 2005
Glyco- and peptidomimetics from three-component Joullié-Ugi coupling show selective antiviral activityTimothy M Chapman, Ieuan G Davies, Baohua Gu, et al.
Chemmedchem|July 29, 2010
Discovery of a novel Hsp90 inhibitor by fragment linkingJohn J Barker, Oliver Barker, Stephen M Courtney, et al.
Canadian Journal of Diabetes|April 13, 2024
Association of Fructosamine Levels With Glycemic Management in Children With Type 1 Diabetes as Determined by Continuous Glucose Monitoring: Results From the CGM TIME TrialKate C Verbeeten, Ken Tang, Jennilea M Courtney, et al.
British Journal of Cancer|November 15, 2000
Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findingsE Tartour, M Mehtali, X Sastre-Garau, et al.
Clinical Pharmacology in Drug Development|May 16, 2023
A Phase 1 First-in-Human Single-Ascending-Dose Trial With ESB1609, a Selective Agonist to the Sphingosine-1-Phosphate Receptor 5Nicholas P France, Christopher Rubino, M Courtney Safir, et al.
Mabs|January 3, 2024
Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector functionJennifer L Schwedler, Maxwell A Stefan, Christine E Thatcher, et al.
The Journal of Arthroplasty|October 23, 2018
Hip and Knee Section, Pathogen Factors: Proceedings of International Consensus on Orthopedic InfectionsJulia Herkenhoff Carijo, Paul M Courtney, Karan Goswami, et al.
Pageof 54